NECAP2 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
CD4-positive, alpha-beta T cell	19 studies	25% ± 9%	Explore
regulatory T cell	18 studies	28% ± 8%	Explore
macrophage	16 studies	25% ± 10%	Explore
endothelial cell	16 studies	25% ± 10%	Explore
non-classical monocyte	12 studies	28% ± 14%	Explore
B cell	11 studies	22% ± 7%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	11 studies	25% ± 8%	Explore
CD8-positive, alpha-beta T cell	11 studies	22% ± 7%	Explore
T cell	9 studies	21% ± 4%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	9 studies	22% ± 9%	Explore
capillary endothelial cell	9 studies	21% ± 8%	Explore
natural killer cell	7 studies	22% ± 4%	Explore
CD16-negative, CD56-bright natural killer cell, human	7 studies	20% ± 4%	Explore
classical monocyte	7 studies	25% ± 10%	Explore
CD4-positive, alpha-beta memory T cell	7 studies	24% ± 6%	Explore
myeloid cell	6 studies	23% ± 8%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	23% ± 7%	Explore
mucosal invariant T cell	5 studies	17% ± 1%	Explore
dendritic cell	5 studies	41% ± 9%	Explore
T follicular helper cell	5 studies	21% ± 4%	Explore
gamma-delta T cell	5 studies	23% ± 12%	Explore
CD16-positive, CD56-dim natural killer cell, human	4 studies	20% ± 3%	Explore
conventional dendritic cell	4 studies	33% ± 11%	Explore
exhausted T cell	4 studies	26% ± 11%	Explore
epithelial cell	4 studies	36% ± 6%	Explore
monocyte	4 studies	22% ± 3%	Explore
ciliated cell	4 studies	25% ± 7%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	27% ± 3%	Explore
innate lymphoid cell	4 studies	17% ± 2%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	32% ± 9%	Explore
CD8-positive, alpha-beta memory T cell	4 studies	25% ± 6%	Explore
memory B cell	4 studies	18% ± 1%	Explore
mature NK T cell	3 studies	19% ± 2%	Explore
leukocyte	3 studies	20% ± 3%	Explore
fibroblast	3 studies	21% ± 5%	Explore
endothelial cell of lymphatic vessel	3 studies	21% ± 6%	Explore
effector CD8-positive, alpha-beta T cell	3 studies	18% ± 2%	Explore
group 3 innate lymphoid cell	3 studies	23% ± 7%	Explore
basal cell	3 studies	25% ± 7%	Explore
plasmacytoid dendritic cell	3 studies	22% ± 9%	Explore
T-helper 1 cell	3 studies	25% ± 2%	Explore
naive B cell	3 studies	20% ± 5%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	10 studies	23% ± 7%	Explore
lung	6 studies	22% ± 3%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	4816.83	578 / 578	100%	45.97	1155 / 1155
ovary	100%	3637.46	180 / 180	100%	32.91	430 / 430
prostate	100%	2801.38	245 / 245	100%	37.83	502 / 502
stomach	100%	2006.27	359 / 359	100%	34.32	286 / 286
uterus	100%	2759.15	170 / 170	100%	48.88	459 / 459
esophagus	100%	2736.54	1444 / 1445	100%	28.51	183 / 183
breast	100%	3655.37	459 / 459	100%	42.37	1117 / 1118
thymus	100%	2920.63	653 / 653	100%	48.94	604 / 605
intestine	100%	2583.61	966 / 966	100%	39.09	526 / 527
skin	100%	4408.36	1809 / 1809	100%	49.54	471 / 472
brain	100%	1717.05	2634 / 2642	100%	50.42	705 / 705
bladder	100%	2827.71	21 / 21	100%	47.01	502 / 504
kidney	100%	3076.57	89 / 89	100%	41.36	897 / 901
liver	100%	1559.54	226 / 226	100%	22.38	404 / 406
pancreas	98%	1297.78	320 / 328	99%	48.82	177 / 178
adrenal gland	100%	3645.28	258 / 258	96%	24.02	220 / 230
adipose	100%	3931.89	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	135.67	29 / 29
spleen	100%	7419.07	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	56.90	45 / 45
ureter	0%	0	0 / 0	100%	19.98	1 / 1
blood vessel	100%	2791.49	1333 / 1335	0%	0	0 / 0
peripheral blood	99%	4209.24	923 / 929	0%	0	0 / 0
eye	0%	0	0 / 0	99%	38.56	79 / 80
heart	97%	1278.61	832 / 861	0%	0	0 / 0
muscle	38%	290.68	308 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0015031	Biological process	protein transport
GO_0016192	Biological process	vesicle-mediated transport
GO_0006897	Biological process	endocytosis
GO_0030125	Cellular component	clathrin vesicle coat
GO_0005905	Cellular component	clathrin-coated pit
GO_0005886	Cellular component	plasma membrane

IV. Literature review

[source]

Gene name	NECAP2
Protein name	Adaptin ear-binding coat-associated protein 2 (NECAP endocytosis-associated protein 2) (NECAP-2) NECAP endocytosis associated 2
Synonyms
Description	FUNCTION: Involved in endocytosis. . FUNCTION: Involved in endocytosis. . FUNCTION: Involved in endocytosis. . FUNCTION: Involved in endocytosis. .
Accessions	ENST00000492095.5 [Q9NVZ3-1] Q9NVZ3 ENST00000707376.1 [Q9NVZ3-2] ENST00000504551.6 ENST00000707379.1 [Q9NVZ3-1] D6RB24 F6SKB8 ENST00000504858.5 ENST00000459640.5 ENST00000443980.6 [Q9NVZ3-2] D6RAN6 ENST00000457722.6 [Q9NVZ3-4] ENST00000337132.10 [Q9NVZ3-1] ENST00000707374.1 [Q9NVZ3-4] ENST00000707372.1 [Q9NVZ3-1] H0Y970 ENST00000513161.1

NECAP2 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review